Global Pharma Healthcare Private Limited manufactures EzriCare Artificial Tears in India. The product is distributed in the United States by Aru Pharma Inc. and Delsam Pharma.
On Feb. 2, 2023, the company voluntarily recalled the product, saying in its risk statement that use of EzriCare Artificial Tears “can result in the risk of eye infections that could result in blindness.”